Product
Dengusiil
Aliases
Live attenuated tetravalent vaccine containing all four dengue virus serotypes (DENV1, 2, 3 and 4)
1 clinical trial
1 indication
Indication
Dengue FeverClinical trial
A Phase 1, Double Blind, Randomized, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of Dengusiil in Healthy AdultsStatus: Completed, Estimated PCD: 2021-06-11